Implementation of a clinical decision support tool to improve the adequate prescription of low-molecular-weight heparins in non-surgical patients. [PDF]
van Gosliga F +3 more
europepmc +1 more source
Deep vein thrombosis prevention and bleeding risks in the cancer patient: are we entering a new era of DVT prophylaxis? [PDF]
Lichliter W.
europepmc +1 more source
ABSTRACT Objectives Polycythemia Vera (PV) is characterized by overproduction of erythrocytes, leading to a hypercoagulable state. Evidence regarding associations between PV and pregnancy outcomes is limited. The aim of our study was to provide robust evidence regarding the prevalence of pregnancy complications in women with PV.
Noah Margolese +5 more
wiley +1 more source
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants. [PDF]
Nagai T +35 more
europepmc +1 more source
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto +12 more
wiley +1 more source
Timing, risk, and reality: early venous thromboembolism chemoprophylaxis in patients with TBI requiring operative intervention. [PDF]
Dhillon NK.
europepmc +1 more source
Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein +6 more
wiley +1 more source
Gut Microbiota Dysbiosis and Risk of Venous Thromboembolism: A Systematic Review. [PDF]
Franco-Moreno A +7 more
europepmc +1 more source
Seventh Åland Island Meeting on von Willebrand Disease
ABSTRACT Introduction The seventh Åland Island Meeting on von Willebrand Disease (VWD) was held on the Åland archipelago in Finland, from 26 to 28 September 2024. Aim The meeting brought together experts in the field of VWD from around the world to share the latest advances and knowledge in VWD.
Riitta Lassila +17 more
wiley +1 more source
Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers. [PDF]
Roy DC +6 more
europepmc +1 more source

